Clinical Trial Update: Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating total neoadjuvant treatment with or without immunotherapy for high-risk locally advanced rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Rectal Cancer | Phase 3 | Status: RECRUITING